I

ICTRIALS Pesquisa e Desenvolvimento | Curitiba, Brazil

Research site

(Unclaimed)

Location

Rua Myltho Anselmo da Silva, 870, Curitiba, Paraná, Brazil

Site insights

Top conditions

Top treatments

ABBV-399

Telisotuzumab

MK-5684

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

The purpose of this study is to assess the efficacy and safety of opevesostat plus hormone replacement therapy (HRT) compared to alternative abirater...

Enrolling

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Prostatic Neoplasms

Drug: Opevesostat

Drug: Dexamethasone

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor,...

Enrolling

Non-Small Cell Lung Cancer

Drug: Telisotuzumab Vedotin

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms